Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1980-04-14
1982-07-13
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
260112R, 424 12, G01N 3356, A61K 4300, C07G 700
Patent
active
043394272
ABSTRACT:
An improved radioimmunoassay for the polypeptidic thymic hormone thymosin.alpha..sub.1 is described. The assay employs a radiolabelled [Tyr.sup.1 ]-thymosin.alpha..sub.1 or [Tyr.sup.1 ]-desacetylthymosin.alpha..sub.1 as probe and an affinity purified thymosin.alpha..sub.1 antibody of improved selectivity.
REFERENCES:
patent: 4264571 (1981-04-01), Goldstein et al.
An Introduction to Radioimmunoassay and Related Techniques, T. Chard, North Holland Publishing Co., New York, 1978, p. 353.
Goldstein Allan L.
McClure John E.
Wang Su-Sun
George Washington University
Gould George M.
Hoffmann-La Roche Inc.
Nucker Christine M.
Saxe Jon S.
LandOfFree
Radioimmunoassay of thymosin.alpha. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioimmunoassay of thymosin.alpha., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioimmunoassay of thymosin.alpha. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-203622